Supplementary Data from Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2⁺ Breast Tumor Microenvironment by Dimitrios N. Sidiropoulos (8812874)

Table_1_Evaluation of a Diagnostic Therapeutic Educational Pathway for Asthma Management in Children and Adolescents.docx by Sebastiano Guarnaccia (8558886)

A sodium channel therapeutic target by Nature Research (16552612)

Supplementary Table 1 from Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors by Sarah E. Fenton (15062814)

Supplementary Figure 3 - Niraparib treatment increases DNA damage and decreases proliferation. from Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsi... by Yevgen Chornenkyy (15072472)

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders by Diane Nugent (14796787)

“…Without disorder-appropriate treatment, affected individuals potentially face life-threatening bleeding, delayed diagnosis, suboptimal management of invasive procedures, psychosocial distress, pain, and decreased quality-of-life.</p> <p>The National Hemophilia Foundation (NHF) and the American Thrombosis and Hemostasis Network identified the priorities of people with inherited BDs and their caregivers, through extensive inclusive community consultations, to inform a blueprint for future decades of research. …”

Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance by Niklas Klümper (15048887)

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research by Shinji Maeda (445222)

Future research directions. by Martha R. Smith (20410184)

Subjects:

Figures 1-3 from Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity by Hayley M. Sabol (14951224)

Supplementary Figure S1 - S7 from Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells by Fiona Simpkins (14986536)

SEC demonstrates that the monomeric population of fALS variants is decreased by <i>S</i>-XL6 treatment and that this is associated with reduced aggregation. by Md Amin Hossain (10170815)

Subjects:

Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. by Livia Vignozzi (22430567)

Figure 4 from OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor–Associated Arthralgia Susceptibility by Hanieh Taheri (20944284)

Mechanisms underlying the therapeutic potential of time-restricted eating in Huntington’s disease. by Russell G. Wells (20933789)

Figure S4 from <i>In Vivo</i> Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target by Ada W.Y. Leung (15009798)

Perceptions about the Therapeutic Itinerary after stroke: a qualitative research by Andreza Maria Luzia Baldo de Souza (12688074)

supplemental figure 3 from Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells by Yijiang Shi (548692)

FIGURE 3 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance by William Echavidre (17597592)

An increase in resource competition within a community results in a decrease in invasion resistance. by Suraya Muzafar (20141845)